Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 181 for “"Tenofovir"”.
-
Tenofovir Induced Nephrotoxicity: A Mechanistic Study
Tenofovir (TFV) is a reverse transcriptase inhibitor that is approved by the United States Food and Drug Administration (FDA) to treat HIV and chronic Hepatitis B. It has a long half-life, allowing for once a day dosing and is effective in treatment of both naive and experienced patients. It is …
-
The effect of tenofovir on bone remodeling.
… the effects of a common HAART medication, tenofovir, on bone cells. It was hypothesized that tenofovir alters the gene expression of osteoblasts and osteoclasts, which creates an imbalance in the bone remodeling system and skeletal change. To test this, mice were treated with tenofovir, …
-
Towards Understanding Tenofovir Disposition: MALDI-Imaging and Pharmacogenetics
… The nucleotide reverse transcriptase inhibitor tenofovir, along with the nucleoside reverse transcriptase inhibitor emtricitabine, currently make up the FDA-approved regimen for pre-exposure prophylaxis. Intracellular phosphorylation of both tenofovir and emtricitabine is necessary to generate …
-
Neurologische unerwünschte Ereignisse Tenofovir-haltiger HIV-Therapie und Prophylaxe
… ist entscheidend für Adhärenz und Wirksamkeit. Tenofovir zählt zu den am häufigsten eingesetzten antiretroviralen Wirkstoffen und ist ein zentraler Bestandteil von ART und PrEP. Neurologische unerwünschte Ereignisse (neurological adverse events, NAEs) wurden jedoch bislang nicht systematisch für …
-
Host modulators of tenofovir exposure and efficacy in the female genital tract
… developed to predict target concentrations of tenofovir diphosphate (TFVdp; active metabolite of tenofovir) in cervical tissue but has not been utilized to capture how vaginal microbiota affects TFVdp exposure in female genital tissue (FGT). The goal of this work was to further optimize the ex …
-
IMPATTO DI COBICISTAT SU DURATA ETOLLERABILITA¿ DI REGIMI ANTIRETROVIRALICONTENENTI TENOFOVIR DIPROXIL FUMARATO
INTRODUZIONE Il dosaggio di tenofovir alafenamide è stato ridotto da 25 a 10 mg al giorno quando somministrato con farmaci con funzioni di potenziatore. Tuttavia, tale riduzione del dosaggio non è mai stata adottata per tenofovir diproxil fumarato. Questo studio vuole valutare l'effetto di …
-
The renal safety profile of tenofovir as used in combination antiretroviral therapy
Background: Tenofovir disoproxil fumarate (TDF) is the prodrug of tenofovir and is currently first-line therapy in adolescents above the age of 15 and adults, according to the consolidated guidelines on the use of antiretroviral therapy (ARV) in South Africa. TDF has proven to be an effective drug …
-
Pharmacogenomics and pharmacokinetics of dolutegravir and tenofovir in Southern Africans living with HIV
… initiating antiretroviral therapy (ART). Tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF) are both prodrugs of tenofovir. However, plasma tenofovir exposure is higher when given as TDF, and TAF yields lower plasma but higher intracellular tenofovir concentrations. …
-
Impact of interindividual differences on muscle-type creatine kinase: implications for tenofovir-based PrEP
Tenofovir (TFV) is a key component to FDA-approved regimens for HIV pre-exposure prophylaxis (PrEP). TFV is a nucleotide analog reverse transcriptase inhibitor prodrug that requires the sequential addition of two phosphate groups by intracellular kinases to produce the pharmacologically active …
-
Effect of oral and gel tenofovir on genital HSV-2 shedding in immunocompetent women
Background: Tenofovir is a potent anti-HIV agent with efficacy in studies of pre-exposure prophylaxis when taken orally or used as an intravaginal gel. Recent studies suggest that tenofovir also reduces the risk of HSV-2 acquisition. Whether oral or gel tenofovir may be useful in HSV disease …
-
Clinical outcomes and renal safety in HIV/AIDS patients on tenofovir-containing regimens in Lesotho
Tenofovir (TDF)-containing highly active antiretroviral therapy (HAART) regimens are the most preferred first-line regimens in the treatment of Human Immunodeficiency Virus/ Acquired Immune Deficiency Syndrome (HIV/AIDS) in Lesotho. Although these regimens have proven efficacious, their use is …
-
A pilot investigation on plasma tenofovir levels and possible side effects in HIV-infected women
Tenofovir disoproxil fumarate (TDF) is a nucleotide reverse transcriptase inhibitor and a prodrug of tenofovir (TFV). It is the currently recommended first line combination treatment of human immunodeficiency virus (HIV) infection in adults. Various clinical studies have associated treatment with a …
-
Systematisches Review und Metaanalyse zu psychiatrischen unerwünschten Ereignissen unter Tenofovir-basierter HIV-Therapie und Prophylaxe
… Gegenstand aktueller Forschung. Obwohl Tenofovir zu den am häufigsten kombinierten Wirkstoffen der HIV-Therapie und -Prophylaxe zählt, ist wenig über das Risiko Tenofovir-basierter Medikation bekannt, psychiatrische „adverse events“ (PAE) auszulösen. Methodik: Um diese Lücke zu …
-
Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections.
… and PLCL EFs, incorporating the antiretroviral, tenofovir disoproxil fumarate (TDF), exhibited sustained-release for up to 4 weeks, and provided complete in vitro protection against HSV-2 and HIV-1 for 24 hr and 2 wk, respectively. In vitro tests confirmed the safety of these fibers in vaginal …
-
3D-Printing of Antiviral Drugs Tenofovir Disoproxil Fumarate and Lamivudine for Point-of-Care Pediatric Drug Delivery
Pediatric population have been deemed as "therapeutic orphans" because overwhelming majority of pharmaceutical products are designed to cater for adult physiology. Pediatric population's rapidly changing body weight and evolving physiologies make it a heterogeneous population. Vast differences …
-
Rates of Switching First-Line Antiretroviral Regimen Tenofovir-Emtricitabine-Efavirenz combination in a Primary Care Service in South Africa
Introduction: Tenofovir-Emtricitabine-Efavirenz (TEE) fixed-dose-combination (FDC) has been recommended since 2013 as the first-line antiretroviral therapy (ART) for treating HIV for people living with the virus (PLWH) in South Africa. More evidence has emerged to show long term adverse effects of …
-
SIDA, un problema por resolver estudio de utilización farmacoeconómico de Tenofovir en el tratamiento antirretroviral de gran actividad (TARGA)
… para combatir el SIDA. Uno de los últimos es el Tenofovir (VIREAD), que constituye el único análogo nucleotídico comercializado hasta el momento en la terapia antirretroviral. Su administración en toma única, su perfil de seguridad óptimo y sus escasas resistencias son algunas de las ventajas de …
-
Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention: prospective studies in HIV-uninfected men and women
… pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF) alone or when co-formulated with emtricitabine (FTC), the same medication used for treatment of HIV infection, is a recommended and highly effective strategy to reduce the risk of sexual acquisition of HIV. The …
Page 1 of 10